Health
PharmAust (ASX:PAA) advances testing against COVID-19 – The Market Herald
Clinical-stage oncology PharmAust (ASX:PAA) has advanced its monepantel drugs testing against COVID-19, in the race to find a vaccine for the virus
- Clinical-stage oncology PharmAust (PAA) has signed an agreement with Leiden University Medical (LUMC) for its monepantel drugs testing against COVID-19
- LUMC will test the effects of monepantel and monepantel sulfone on the replication of SARS-CoV-2 in cell lines
- Under the agreement, PharmAust will pay a fee to LUMC and will own all intellectual property results generated from the study
- The study will be overseen by Dr Martijn van Hemert, Principal Investigator of …
Continue Reading
-
General16 hours ago‘We are here for you’: PM to bring help to flood zones
-
General15 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News22 hours agoStudents say new facility would be better in rural areas of Queensland
-
General14 hours agoTrump, Vietnam’s Lam agree to discuss tariffs deal